#United States #Philadelphia #Sellers Dorsey #Kevin Seabaugh #Martin Sellers

Sellers Dorsey's New Era of Leadership

In a notable shift in leadership, Sellers Dorsey, a key player in the Medicaid landscape, has announced that Martin Sellers, its co-founder and long-time CEO, will retire from his position effective December 2, 2024. His successor, Kevin Seabaugh, a seasoned leader in healthcare innovation and business development, will step into his shoes as the new Chief Executive Officer. This transition marks a pivotal moment in the evolution of the firm, with hopes of furthering its mission to improve healthcare services for vulnerable populations across the United States.

Martin Sellers, who co-founded the organization in 2002, has been at the helm for over two decades, steering the company from a modest consultancy into a nationally recognized firm focused on Medicaid impact. According to Sellers, leading this firm has been one of his greatest privileges. He proudly reflects on the organization's growth and accomplishments in providing better access to quality healthcare for millions, commenting, "Sellers Dorsey has become one of the nation's most respected Medicaid impact firms, improving access for millions of Americans."

Transitioning to the role of Executive Chairman of the Board, Martin will continue to lend his expertise and vision to the firm, ensuring that the mission of supporting underserved communities remains intact as leadership evolves. He believes Kevin Seabaugh is the right leader to take the company further into the future, saying, "Kevin has a deep understanding of healthcare and a proven ability to drive transformational results." Martin Sellers emphasized the importance of effective leadership in navigating the rapidly changing healthcare environment, as well as the company's commitment to quality care for underserved communities.

Kevin Seabaugh brings with him over 20 years of experience in healthcare innovation, having held prominent positions such as leading commercial strategies at apree health and managing population health initiatives at Cerner Corporation. His extensive background uniquely positions him to lead Sellers Dorsey into its next chapter. Upon accepting the role, Kevin positioned himself as a steward of both tradition and innovation, stating, "I am honored to join Sellers Dorsey as CEO. Together with our talented team, we will continue to make a meaningful impact by improving healthcare outcomes for those who need it most."

As the Medicaid landscape continues to evolve, Sellers Dorsey is set to play a crucial role in advocating for policy and funding that supports safety-net hospitals and underserved populations. With Martin Sellers' legacy guiding the transition and Kevin Seabaugh stepping into the leadership role, the firm is positioned to address the challenges of the healthcare systems and deliver transformative results.

In conclusion, this leadership transition at Sellers Dorsey represents not just a change in personnel but a significant step toward further innovating and enhancing healthcare access across the nation. With both leaders committed to the organization's core mission, the firm is poised to continue its important work in Medicaid impact and healthcare improvement, fostering a healthier future for underserved communities. This change also serves as a reminder that effective leadership is key to addressing the complexities within the healthcare landscape, particularly for those who rely on safety-net services.